Pneumocystis Jirovecii Pneumonia
Introduction[edit | edit source]
Pneumocystis JIrovecii Pneumonia (PJP) was previously called as Pneumocystis Carinii Pneumonia (PCP), it is one of the most common opportunistic fungal infection in immuno-compromised conditions such as haematological malignancy, congenital immunodeficiency, organ transplantation, immunosuppressive therapy, under medication and predominantly in HIV. [1]
Epidemiology[edit | edit source]
Etiology[edit | edit source]
The pathogen responsible for PJP is Pneumocystis Jirovecii, an organism classified as a fungus.
Pathophysiology[edit | edit source]
Signs and Symptoms[edit | edit source]
- Exertional dyspnea
- Dry and non-productive cough
- Fever
- Tachypnea
- Tachycardia
- Cyanosis
Diagnostic Procedures[edit | edit source]
Differential Diagnosis[edit | edit source]
Prognosis[edit | edit source]
Pharmacological Management[edit | edit source]
Physiotherapy Intervention[edit | edit source]
Resources[edit | edit source]
References[edit | edit source]
- ↑ Ricciardi A, Gentilotti E, Coppola L, Maffongelli G, Cerva C, Malagnino V, et al. Infectious disease ward admission positively influences P. jiroveci pneumonia (PJP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. PLoS ONE. 2017;12(5):e0176881.